Holy Cross grad aims to lead Phio Pharmaceuticals cancer research into clinical development

Marlborough biopharma Phio Pharmaceuticals is ushering in a new strategic plan seeking to reposition the company from pure discovery research to full development, utilizing clinical trials.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Robert Bitterman ,Gerrit Dispersyn ,Phio Pharmaceuticals ,College Of The Holy Cross ,Cutanea Life Sciences ,Boston University ,Phio Pharmaceutical ,Holy Cross ,